PHXPHARMX TECHNOLOGIES LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 20 Aug 2026, 20:36 | Notice of FY26 Results Announcement | Presentations | — | 03027, 14014 | |
| 11 July 2026, 02:01 | Cleansing Notice | Securities Administration | — | 06018 | |
| 11 July 2026, 01:56 | Application for quotation of securities - PHX | Other | — | 06020 | |
| 11 July 2026, 01:52 | Sigma Healthcare 10% strategic holding now complete | Substantial Holders | — | 02006 | |
| 7 July 2026, 19:12 | Pharmx Renews National NDSS Agreement | Company Update | — | 11001 | |
| 29 June 2026, 19:53 | Agreement of first work item under Sigma Strategic Alliance | Company Update | — | 11001 | |
| 17 June 2026, 19:52 | Notice of Investor Presentation | Presentations | — | 03026 | |
| 5 May 2026, 21:46 | Q3 Investor Update FY2026 | Periodic Reports | — | 03014 | |
| 13 Mar 2026, 22:52 | Initial Director's Interest Notice - M Conway | Director Interests | — | 02008 | |
| 13 Mar 2026, 22:50 | Director Appointment | Company Administration | — | 12001 | |
| 12 Mar 2026, 21:59 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 27 Feb 2026, 03:31 | Cleansing Notice | Securities Administration | — | 06018 | |
| 27 Feb 2026, 03:27 | Application for quotation of securities - PHX | Other | — | 06020 | |
| 25 Feb 2026, 19:32 | H1 FY26 Investor Presentation | Financial Results | MS | 03002, 03004, 03026 | |
| 25 Feb 2026, 19:27 | H1 FY26 Results Announcement | Financial Results | MS | 03004 | |
| 25 Feb 2026, 19:26 | Half Yearly Reports & Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 23 Feb 2026, 19:47 | Proposed issue of securities - PHX | Securities Administration | — | 06013 | |
| 23 Feb 2026, 19:27 | Pharmx and Sigma enter multi-year strategic alliance | Company Update | MS | 11001 | |
| 4 Feb 2026, 20:13 | Notice of Results Announcement - 31 December 2025 | Other | — | 03027 | |
| 11 Nov 2025, 22:52 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 11 Nov 2025, 20:38 | Chairman's Address & CEO Presentation | Presentations | — | 03026, 15002 | |
| 11 Nov 2025, 19:26 | Pharmx launches new Marketplace platform | Company Administration | — | 12008 | |
| 10 Oct 2025, 20:43 | Notice of Annual General Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 8 Oct 2025, 03:23 | Update - Notification of cessation of securities - PHX | Other | — | 06027 | |
| 8 Oct 2025, 03:17 | Notification of cessation of securities - PHX | Other | — | 06027 | |
| 8 Oct 2025, 03:15 | Notification regarding unquoted securities - PHX | Other | — | 06021 | |
| 8 Oct 2025, 03:13 | Application for quotation of securities - PHX | Other | — | 06020 | |
| 25 Sept 2025, 19:25 | Update on Pharmacy Portal - StockView Feature Introduction | Company Administration | — | 12008 | |
| 13 Sept 2025, 02:49 | 2025 Annual General Meeting - Key Dates | Meetings & Governance | — | 08006, 12008 | |
| 2 Sept 2025, 03:35 | Initial Director's Interest Notice - A Mellis | Director Interests | — | 02008 | |
| 2 Sept 2025, 03:35 | Final Director's Interest Notice - A Mellis | Director Interests | — | 02010 | |
| 2 Sept 2025, 03:33 | Final Director's Interest Notice - D Bastas | Director Interests | — | 02010 | |
| 2 Sept 2025, 03:32 | Director Changes & Office Address Update | Company Administration | — | 12001, 12003 | |
| 20 Aug 2025, 19:10 | Investor Presentation | Financial Results | MS | 03003, 03026 | |
| 20 Aug 2025, 19:09 | FY25 Results | Financial Results | MS | 03003, 03014 | |
| 20 Aug 2025, 19:04 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 20 Aug 2025, 19:04 | Appendix 4E & FY2025 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 13 Aug 2025, 19:23 | Notice of Results Announcement | Presentations | — | 03027, 14014 |
1–38 of 38
1 / 1